BLFS - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi biolifesolutions.com
The "razor and blade" model featuring high-margin consumables for cryochambers drives the dynamics of the base EBITDA, where 6.36 captures the value of this parameter. Management's strategy to create an indispensable biomaterial logistics infrastructure strengthens the position of BioLife Solutions, Inc. (BLFS). Current profit growth is based on demand in gene therapy and the gradual implementation of automated hubs.
Ringkesan rincian data analitis BioLife Solutions (BLFS)
- nilai saham lan prakiraan konsensus rega:
- statistik kapitalisasi pasar:
- indikator kapitalisasi buku:
- rincian struktur utang lan likuiditas bisnis:
Koefisien Total Utang marang Modal BioLife Solutions, Inc.|BLFS - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal BioLife Solutions Inc|BLFS - Utang perusahaan|Rasio utang marang kapitalisasi buku BioLife Solutions|BLFS - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan BioLife Solutions|Rasio likuiditas perantara biolifesolutions.com
- rincian bathi lan kelipatan pasar:
BLFS - Bathi resik|Prakiraan bathi perusahaan BioLife Solutions, Inc.|BLFS - Rasio rega marang bathi|Rasio prakiraan rega marang bathi biolifesolutions.com|BLFS - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan BioLife Solutions|BLFS - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone patang kuartal pungkasan BioLife Solutions|BLFS - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan biolifesolutions.com|BLFS - Wutah bathi ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep BioLife Solutions, Inc.
Analisis kabeh metrik perusahaan:BioLife (BLFS)
Professional asset selection is based on an analysis of the stability of cash flows from core operations. This metric aggregates operating profit before depreciation and amortization, excluding the impact of tax and credit policies. EBITDA dynamics reflect the business's actual ability to generate liquidity. For BioLife Solutions, Inc. (BLFS), this confirms the effectiveness of scaling within the cryopreservation segment. The upward trend of the curve proves the company's indispensability in regenerative medicine supply chains.
Analisis pesaing BioLife Solutions, Inc.
Pendapatan operasional sadurunge ngurangi amortisasi Tempus (TEM)|Qiagen N.V. - Bathi operasional EBITDA|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi IONS|RGEN: Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Avidity Biosciences Inc (RNA)|Bathi operasional sadurunge ngurangi amortisasi CRSP|WGS: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Ultragenyx Pharmaceutical (RARE)|Pendapatan operasional sadurunge ngurangi amortisasi beamtx.com|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Sarepta SRPT|Twist Bioscience Inc (TWST) - Bathi sadurunge bunga, pajak, lan amortisasi|TXG - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|NTLA: Bathi sadurunge mbayar bunga, pajak, lan amortisasi|STOK (Stoke Therapeutics) - Bathi operasional sadurunge ngurangi amortisasi|wavelifesciences.com (WVE) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi MAZE|SION (Sionna Therapeutics, Inc.) - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi operasional EBITDA PRME|Pendapatan operasional sadurunge ngurangi amortisasi Taysha Corp|Bathi sadurunge mbayar bunga, pajak, lan amortisasi uniQure N.V. QURE|meiragtx.com (MGTX) - Bathi sadurunge bunga, pajak, lan amortisasi|RGNX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|SLDB (Solid Biosciences Inc) - Bathi operasional sadurunge amortisasi|Ocugen Corp (OCGN) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|PACB - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge ngurangi amortisasi BNTC|DSGN: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA RCKT|Pendapatan operasional sadurunge ngurangi amortisasi 4DMT|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Lexeo Therapeutics, Inc. LXEO|KRRO: Bathi operasional sadurunge amortisasi|Editas Medicine, Inc. - Bathi operasional EBITDA|silence-therapeutics.com (SLN) - Bathi operasional sadurunge ngurangi amortisasi|PRQR (proqr.com) - Bathi operasional sadurunge ngurangi amortisasi|CDXS - Pendapatan operasional sadurunge ngurangi amortisasi|SGMO (Sangamo) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi NAUT|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Metagenomi, Inc. (MGX)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi DTIL (precisionbiosciences.com)|Bathi operasional EBITDA GBIO (Generation Bio)|BOLD (Boundless Bio Inc.) - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|XCUR - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan operasional sadurunge ngurangi amortisasi Imunon, Inc. IMNN|PHIO: Bathi operasional EBITDA|Bathi operasional sadurunge amortisasi MBIO|Bathi sadurunge mbayar bunga, pajak, lan amortisasi TransCode Therapeutics Inc.|Bathi operasional sadurunge amortisasi BNGO (Bionano)|Bathi operasional EBITDA APDN|Bathi operasional EBITDA bluebird bio, Inc (BLUE)|Bathi operasional EBITDA IPA (ImmunoPrecise Antibodies Ltd.)|omegatherapeutics.com - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Singular Genomics - Bathi operasional EBITDA|Pendapatan operasional sadurunge ngurangi amortisasi Regulus Therapeutics, Inc. RGLS|Syros (SYRS) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi Telesis Bio, Inc (TBIO)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi TRACON Pharmaceuticals|Bathi sadurunge mbayar bunga, pajak, lan amortisasi UBX
